Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Net Income (Common)
Shandong Pharmaceutical Glass Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Net Income (Common)
¥737.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Net Income (Common)
¥2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Net Income (Common)
¥1.7B
|
CAGR 3-Years
45%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Net Income (Common)
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Net Income (Common)
¥666.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Net Income (Common)?
Net Income (Common)
737.7m
CNY
Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Net Income (Common) amounts to 737.7m CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
19%
Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for Shandong Pharmaceutical Glass Co Ltd have been 12% over the past three years , 18% over the past five years , and 19% over the past ten years .